Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
375 hedge funds and large institutions have $7.06B invested in Amedisys in 2021 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 131 increasing their positions, 139 reducing their positions, and 56 closing their positions.
2.23% more ownership
Funds ownership: 86.78% → 89.01% (+2.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 139
3% less funds holding
Funds holding: 388 → 375 (-13)
6% less capital invested
Capital invested by funds: $7.52B → $7.06B (-$459M)
18% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 56
56% less call options, than puts
Call options by funds: $20.3M | Put options by funds: $46.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$91.5M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$52.4M |
| 3 |
Morgan Stanley
New York
|
+$26.8M |
| 4 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$25.9M |
| 5 |
JP Morgan Chase
New York
|
+$25.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$49.9M |
| 2 |
BlackRock
New York
|
-$44.2M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$36.3M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$29.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$26.2M |
AMED Hedge Fund Activity: Q2 2021 in Review
375 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2021, worth a combined $7.06B — down 6.1% from $7.52B a quarter earlier.
Sellers outnumbered buyers: 56 funds closed out of AMED and 46 opened new positions — a net loss of 10 holders — while 139 trimmed existing stakes and 131 added.
The largest buyer was Ameriprise, adding an estimated $91.5M. The largest seller was Wells Fargo, cutting an estimated $49.9M.
- 375 institutional investors held Amedisys (AMED) as of Q2 2021, down from 388 in Q1 2021.
- Funds reported $7.06B of Amedisys stock for Q2 2021, down 6.1% quarter-over-quarter.
- 46 funds opened new Amedisys positions in Q2 2021 and 56 closed out, a net change of -10 holders.
- The largest Amedisys buyer in Q2 2021 was Ameriprise, an estimated $91.5M added.
- The largest Amedisys seller in Q2 2021 was Wells Fargo, an estimated $49.9M sold.
Based on aggregated 13F filings for Q2 2021.